I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 11 studies | 29% ± 11% | |
| endothelial cell | 9 studies | 27% ± 7% | |
| glutamatergic neuron | 6 studies | 40% ± 21% | |
| epithelial cell | 6 studies | 31% ± 13% | |
| astrocyte | 6 studies | 24% ± 7% | |
| natural killer cell | 5 studies | 17% ± 1% | |
| oligodendrocyte precursor cell | 5 studies | 26% ± 7% | |
| neuron | 4 studies | 31% ± 7% | |
| fibroblast | 4 studies | 19% ± 2% | |
| GABAergic neuron | 4 studies | 42% ± 15% | |
| interneuron | 4 studies | 34% ± 18% | |
| oligodendrocyte | 4 studies | 22% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% | |
| microglial cell | 3 studies | 17% ± 1% | |
| type I pneumocyte | 3 studies | 21% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 2% | |
| dendritic cell | 3 studies | 26% ± 8% | |
| abnormal cell | 3 studies | 23% ± 3% | |
| basal cell | 3 studies | 29% ± 6% | |
| transit amplifying cell | 3 studies | 22% ± 4% | |
| goblet cell | 3 studies | 18% ± 1% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 3% |
